Stock Events

Stock Events

Genex Pharmaceutical 

$0.000200
2
+$0.00+100%Thursday 14:58

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0002
52W Low
0.0001
Volume
10,000
Avg. Volume
3,125
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

May 23Expected
Q2 2006
Q3 2006
Q4 2006
Q1 2007
Q2 2007
Q4 2007
Q1 2008
0
0
0.01
0.01
Expected EPS
0
Actual EPS
0.01

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a major player in the pharmaceutical industry, directly competing in several therapeutic areas with Genex.
Merck
MRK
Mkt Cap368.89B
Merck operates globally in many of the same segments as Genex, including oncology and vaccines.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson offers a broad range of pharmaceutical products that compete across multiple segments with Genex.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline competes in the pharmaceutical and healthcare sectors, overlapping with Genex's market.
Novartis
NVS
Mkt Cap303.67B
Novartis is known for innovation in pharmaceuticals, directly competing with Genex in research and drug development.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie operates in similar therapeutic areas as Genex, particularly in immunology and oncology.
AMGEN
AMGN
Mkt Cap251.94B
Amgen focuses on biologic medicines, competing with Genex in biopharmaceutical products.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb has a strong presence in areas like cancer and cardiovascular diseases, competing with Genex.
Lilly(Eli) &
LLY
Mkt Cap1.26T
Eli Lilly is a key competitor in diabetes and cancer drug markets, areas where Genex also operates.
Sanofi
SNY
Mkt Cap106.24B
Sanofi's broad range of pharmaceutical products makes it a direct competitor in multiple markets with Genex.

About

Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.
Show More
CEO
Fuzhi Song
Employees
86
Country
United States
ISIN
US37227T1051

Listings

OTC Link
US
GENX

0 Comments

Share your thoughts

FAQs

What is Genex Pharmaceutical stock price today?▼
The current price of GENX is $0.00 USD — it has increased by +100% in the past 24 hours. Watch Genex Pharmaceutical stock price performance more closely on the chart.
What is Genex Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Genex Pharmaceutical stocks are traded under the ticker GENX.
Is Genex Pharmaceutical stock price growing?▼
GENX stock has risen by +100% compared to the previous week, the month change is a +100% rise, over the last year Genex Pharmaceutical has showed a +100% increase.
What were Genex Pharmaceutical earnings last quarter?▼
GENX earnings for the last quarter are 0.01 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Genex Pharmaceutical have?▼
As of November 2, 2026, the company has 86 employees.
In which sector is Genex Pharmaceutical located?▼
Genex Pharmaceutical operates in the Health & Wellness sector.
When did Genex Pharmaceutical complete a stock split?▼
The last stock split for Genex Pharmaceutical was on July 1, 2004 with a ratio of 4:1.
Where is Genex Pharmaceutical headquartered?▼
Genex Pharmaceutical is headquartered in Tianjin, United States.